Oisin Biotechnologies Company
Oisin Biotechnologies is a drug development company focused on mitigating the senolytic technology to combat age-related diseases.
Headquarters:
Seattle, Washington, United States
Number Of Exists:
11-50
Total Funding:
7.1M
Founded Date:
2014
Employee Number:
11-50
Last Funding Type:
seed round
Investor Type:
For Profit
Investors Number:
6
Last Funding Date:
May 27, 2021
Technology:
Geroscience
Funding Status:
Seed
Industry:
Biopharma, Biotechnology, Gene therapy, Medical